You are here

gastric cancer

How Astellas juggles the moving parts of cancer precision medicine development

Pharma Voice

Thu, 12/5/24 - 11:05 am

precision medicine

Astellas nabs class-first FDA approval for CLDN18.2 gastric cancer med Vyloy

Fierce Pharma

Sun, 10/20/24 - 10:22 pm

Experts support FDA's plan for restrictions on PD-1 drugs in stomach, esophageal cancers

Fierce Pharma

Thu, 09/26/24 - 06:35 pm

PD-1 inhibitors

esophageal cancer

Astellas' gastric cancer therapy gets UK regulator's nod

Reuters

Wed, 08/14/24 - 11:19 am

monoclonal antibodies

Merck reports data from Phase III gastric cancer treatment trial

Clinical Trials Arena

Thu, 05/2/24 - 11:23 am

clinical trials

AACR: Merck, Kelun’s Anti-TROP2 ADC Shows Early Promise in Gastric Cancer

BioSpace

Wed, 04/10/24 - 09:59 am

antibody-drug conjugate

clinical trials

FDA declines to approve Astellas' gastric cancer drug

Reuters

Tue, 01/9/24 - 09:39 am

Merck Expands Keytruda’s Label as a First-Line Option for Gastric Cancer

BioSpace

Fri, 11/17/23 - 11:48 am

Astellas' Zolbetuximab Is a Promising Therapy for HER2-Negative Gastric Cancer

Xtalks

Mon, 07/17/23 - 06:54 pm

BeiGene's gastric cancer drug succeeds in late-stage trial

Reuters

Thu, 04/20/23 - 11:41 am

clinical trials

Astellas Announces Positive Findings from Phase 3 GLOW Trial of Zolbetuximab during March ASCO Plenary Series

Drugs.com

Thu, 03/23/23 - 11:41 am

clinical trials

AstraZeneca strengthens its oncology R&D with in-licensing of CMG901 from China-based biotech KYM Biosciences

Medical Marketing and Media

Fri, 02/24/23 - 09:16 am

antibody-drug conjugate

KYM Biosciences

Astellas’ Phase III gastric cancer therapy trial meets primary endpoint

Clinical Trials Arena

Fri, 12/16/22 - 10:21 am

clinical trials

Astellas' $1.3B antibody strikes first in hot cancer field, extending survival in phase 3

Fierce Biotech

Thu, 11/17/22 - 10:37 am

clinical trials

Hutchmed reports positive data from gastric cancer therapy trial

Clinical Trials Arena

Mon, 11/14/22 - 07:09 pm

clinical trials

Elevation Oncology dips its toes into ADCs, adding second drug to its bag.

Endpoints

Thu, 07/28/22 - 06:32 pm

Elevation Oncology

pancreatic cancer

antibody-drug conjugate

Keytruda should lose stomach cancer indication, says ODAC

Pharmaforum

Fri, 04/30/21 - 11:09 am

Amgen's promising gastric cancer drug makes good on Five Prime potential with FDA's breakthrough nod

Endpoints

Tue, 04/20/21 - 11:13 am

clinical trials

Bristol Myers’ Opdivo Receives FDA Approval for Gastric Cancer

BioSpace

Mon, 04/19/21 - 10:32 pm

Bristol Myers Squibb

Amgen adds gastric cancer drug candidate in $1.9 billion Five Prime Therapeutics deal

Reuters

Thu, 03/4/21 - 10:29 am

Five Prime Therapeutics

Pages